Applying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.
Gary Dailey
Advertisement
Gary Dailey is vice-president, Global Marketing, Electronic Materials, at Avantor.
Articles by Gary Dailey
Advertisement
Latest Updated Articles
Applying Lessons Learned from the Semiconductor IndustryNovember 1st 2019
Advertisement
Advertisement
Trending on BioPharm International
1
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
2
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
3
What 3 Principles Guide Merck's Biologics and ADC Capacity Placement?
4
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
5